Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baltazar Gomez-Mancilla

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Science Translational Medicine|April 28, 2012
Tweaking the social networkBaltazar Gomez-Mancilla
Proteome Science|April 29, 2006
Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluidNelson Guerreiro, Baltazar Gomez-Mancilla, Stéphane Charmont
Journal of Alzheimer'S Disease : JAD|March 13, 2008
Proteomic 2-D DIGE profiling of APP23 transgenic mice brain from pre-plaque and plaque phenotypesNelson Guerreiro, Matthias Staufenbiel, Baltazar Gomez-Mancilla
Parkinson'S Disease|July 16, 2013
Metabotropic glutamate receptors for Parkinson's disease therapyFabrizio Gasparini, Thérèse Di Paolo, Baltazar Gomez-Mancilla
Developmental Neurobiology|May 23, 2013
Molecular basis for prospective pharmacological treatment strategies in intellectual disability syndromesChiara Verpelli, Ivan Galimberti, Baltazar Gomez-Mancilla, et al.
Current Opinion in Psychiatry|November 26, 2013
Obsessive compulsive disorder and the glutamatergic systemCatherine Kariuki-Nyuthe, Baltazar Gomez-Mancilla, Dan J Stein
Current Opinion in Drug Discovery & Development|August 30, 2008
mGluR5 antagonists: discovery, characterization and drug developmentFabrizio Gasparini, Graeme Bilbe, Baltazar Gomez-Mancilla, et al.
BMC Medical Genetics|March 9, 2012
The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitroElisabetta Tabolacci, Filomena Pirozzi, Baltazar Gomez-Mancilla, et al.
Neuropharmacology|January 16, 2010
Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeysNicolas Morin, Laurent Grégoire, Baltazar Gomez-Mancilla, et al.
Psychopharmacology|November 16, 2013
Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug developmentAndreea S Pop, Baltazar Gomez-Mancilla, Giovanni Neri, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Science Translational Medicine|April 28, 2012
Tweaking the social networkBaltazar Gomez-Mancilla
Proteome Science|April 29, 2006
Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluidNelson Guerreiro, Baltazar Gomez-Mancilla, Stéphane Charmont
Journal of Alzheimer'S Disease : JAD|March 13, 2008
Proteomic 2-D DIGE profiling of APP23 transgenic mice brain from pre-plaque and plaque phenotypesNelson Guerreiro, Matthias Staufenbiel, Baltazar Gomez-Mancilla
Parkinson'S Disease|July 16, 2013
Metabotropic glutamate receptors for Parkinson's disease therapyFabrizio Gasparini, Thérèse Di Paolo, Baltazar Gomez-Mancilla
Developmental Neurobiology|May 23, 2013
Molecular basis for prospective pharmacological treatment strategies in intellectual disability syndromesChiara Verpelli, Ivan Galimberti, Baltazar Gomez-Mancilla, et al.
Current Opinion in Psychiatry|November 26, 2013
Obsessive compulsive disorder and the glutamatergic systemCatherine Kariuki-Nyuthe, Baltazar Gomez-Mancilla, Dan J Stein
Current Opinion in Drug Discovery & Development|August 30, 2008
mGluR5 antagonists: discovery, characterization and drug developmentFabrizio Gasparini, Graeme Bilbe, Baltazar Gomez-Mancilla, et al.
BMC Medical Genetics|March 9, 2012
The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitroElisabetta Tabolacci, Filomena Pirozzi, Baltazar Gomez-Mancilla, et al.
Neuropharmacology|January 16, 2010
Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeysNicolas Morin, Laurent Grégoire, Baltazar Gomez-Mancilla, et al.
Psychopharmacology|November 16, 2013
Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug developmentAndreea S Pop, Baltazar Gomez-Mancilla, Giovanni Neri, et al.
Pageof 6